Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.59 USD | +6.00% | +7.84% | +0.44% |
10/05 | Edesa Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 | CI |
05/03 | Top Premarket Gainers | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.39Cr | - | - | - | - | - | |
12TCr | ||||||
11TCr | ||||||
2.43TCr | - | |||||
2.2TCr | - | |||||
1.82TCr |
- Stock Market
- Equities
- EDSA Stock
- Charts Edesa Biotech, Inc.
- Sector Chart